Infantile HemiplegiaRIPHIGEONCT04246788
Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM
A study testing Intensive robotic rehabilitation and classical physiotherapy in people with Infantile Hemiplegia, run by University Hospital, Clermont-Ferrand at 1 site in France.
Trial summary
Cerebral palsy is the most frequent motor deficiency in children. Among other, it can leads to spastic diplegia or hemiplegia. Walking abilities is an important skill to the families' point of view in term of independence in curent life. Read more about this study
- Who is it for?
- Ages 4 to 18 years
- Conditions the study is for
- Infantile Hemiplegia
- What is being tested?
- Intensive robotic rehabilitation and classical physiotherapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteFrance
- Study dates
- 17 Jul 2020to 24 Nov 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 4 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Hemiplegic children aged from 4 to 18 years
- GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement.
- Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
- Free and informed consent of holders of parental authority and of the patient
- Affiliated to the social security system
Who cannot join
- No lower limb involvement,
- spasticity = 4 on the modified Ashworth scale,
- severe cardiorespiratory disease forbidding the rehabilitation program,
- orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.
Trial locations and contacts
1 site in 1 country.
About this study
Cerebral palsy is the most frequent motor deficiency in children. Among other, it can leads to spastic diplegia or hemiplegia. Walking abilities is an important skill to the families' point of view in term of independence in curent life. Improving the walking parameters has been the main objective in several studies of rehabilitation. The G-EO system is a last generation robot assisting gait training that can adjust cadence, walk lengh, ankle and hip angles and other walking parameters to movement captation. Its superiority in terms of walking abilities has been demonstrated in adults with stroke sequelae. Only one study was realized in pediatric patients with spastic diplegia with promising results. The investigators hypothesize that intensive robot-assited gait training using the G-EO system in hemiplegic children can improve their walking abilities.
Read the detailed description
Objective :
Primary objective: To evaluate walking velocity with the GRAIL (gait real-time analysis and interactive lab) after intensive robot-assisted gait training using the G-EO system in hemiplegic children.
Secondary objectives :Other parameters that will be evaluate include:
- Endurance on the 6 minute walking test
- Joint angles and muscular contraction on the GRAIL
- Number of steps and travelled distance /24h, cardiac frequency and quality of sleep using actimeter bracelet
- Motor functions using the GMFM (Gross Motor Function Measure)
- Spasticity using the modified Ashworth scale
- The functional independence using the Functional Independence Measure (FIM™) for children,
- The quality of life using the Patient Global Impression (PGI-I)
- Muscular strength using the muscular testing cotation scale
- The musculo-squeletal and adipose composition using the peripherical quantitative computed tomography (pQCT)
- The cerebral area activation using functional MRI Study Type: Controlled randomized pilote study Number of centres: Monocentric study, University hospital of Clermont-Ferrand
Study procedure:
- Experimental group: 5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
- Control group : 3 sessions per week of 30 minutes of classical physiotherapy during two weeks
Study evaluation:
T0 : before rehabilitation :
- Actimeter for 24h
- 6 min walking test
- GRAIL
- Modified Ashworth scale
- FIM for children
- GMFM
- Muscular testing scale
- pQCT
- fMRI
T1 : one month after rehabilitation :
- idem T0
- PGI-I questionnary Principal judgement criteria: Walking velocity Secondary judgement criteria: endurance, joint angles, number of steps and travelled distance per 24h, quality of sleep, cardiac frequency, spasticity, functional independence, motor functions, muscular strength, musculo-squeletal and adipose composition, brain activated areas.
Number of subjects:
- 20 patients in the experimental group
- 20 patients in the control group All patients enrolled in the control group will benefit of the GEOsystem rehabilitation at the end of the protocole
Inclusion criteria:
Hemiplegic children aged from 4 to 18 years, with a GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement. Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
Non inclusion criteria:
No lower limb involvement, spasticity = 4 on the modified Ashworth scale, severe cardiorespiratory disease forbidding the rehabilitation program, orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.
Study calendar:
- Starting inclusions: March 2020
- Experimental procedure: March 2020 to March 2021
- Data analyses and synthesis: April 2021 to Dember 2021
Statistical analyses Statistical analysis will be performed using Stata 13 software (Stata-Corp, College Station, TX) by an experimented statistician (Bruno Pereira) working in the university hospital of Clermont-Ferrand. A type-I error set at α=0.05 will be considered. Monovariate and multivariate analyses considering age as a covariable will be performed.
Ethical considerations This study has already been presented at the local ethical committee and will be presented in July 2019 at the national " comité de protection des personnes ". Written informed consent from both parents will be collected at the inclusion. This study will be in agreement with the declaration of Helsinki and the current regulations of clinical trials. It will be declared on the internet site "clinicaltrials.gov".
Expected results :
Intensive robot-assisted gait training using the G-EO system may improve the walking abilities in children with infantile hemiplegia and consequently improve their independence and quality of life. Musculo-squeletal parameters and profile of cerebral activated areas involved in praxia may also be modified by this intensive rehabilitation.
- Conditions
- Infantile Hemiplegia
- Being tested
- Intensive robotic rehabilitation, classical physiotherapy
- Keywords
- Infantile hemiplegia, Cerebral palsy, Intensive robotic rehabilitation
- Medical subject headings
- Hemiplegia, Cerebral Palsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intensive robotic rehabilitationOther
5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
classical physiotherapyOther
3 sessions per week of 30 minutes of classical physiotherapy during two weeks
| Study group | Role | What they receive |
|---|---|---|
| Cohort 1 : experimental group | Experimental | 5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks Receives: Other: Intensive robotic rehabilitation |
| Cohort 2 : controle group | Active comparator | 3 sessions per week of 30 minutes of classical physiotherapy during two weeks Receives: Other: classical physiotherapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Gait speed
gait speed assessed during a gait assessment session using the GRAIL system
Measured: day 1
Gait speed
gait speed assessed during a gait assessment session using the GRAIL system
Measured: day 21
Gait speed
gait speed assessed during a gait assessment session using the GRAIL system
Measured: day 51
Secondary outcomes (36)
6 min. walk test (6-WT)
endurance evaluation by 6 min. walk test (6-WT)
Measured: day 1
6 min. walk test (6-WT)
endurance evaluation by 6 min. walk test (6-WT)
Measured: day 21
6 min. walk test (6-WT)
endurance evaluation by 6 min. walk test (6-WT)
Measured: day 51
joint angles
Joint amplitudes measured during gait assessment with the GRAIL
Measured: day 1
joint angles
Joint amplitudes measured during gait assessment with the GRAIL
Measured: day 21
joint angles
Joint amplitudes measured during gait assessment with the GRAIL
Measured: day 51
number of steps per 24h
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 1
number of steps per 24h
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 21
number of steps per 24h
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 51
travelled distance
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 1
travelled distance
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 21
travelled distance
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 51
quality of sleep: wristband actimeter
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 1
quality of sleep: wristband actimeter
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 21
quality of sleep: wristband actimeter
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 51
cardiac frequency
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 1
cardiac frequency
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 21
cardiac frequency
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Measured: day 51
Evaluation of spasticity
Evaluation of spasticity by the modified Ashworth scale
Measured: day 1
Evaluation of spasticity
Evaluation of spasticity by the modified Ashworth scale
Measured: day 21
Evaluation of spasticity
Evaluation of spasticity by the modified Ashworth scale
Measured: day 51
functional independence
Overall functional independence assessed with the MIF-Môme autonomy scale
Measured: day 1
functional independence
Overall functional independence assessed with the MIF-Môme autonomy scale
Measured: day 21
functional independence
Overall functional independence assessed with the MIF-Môme autonomy scale
Measured: day 51
motor functions
Overall motor function evaluated with the EMFG
Measured: day 1
motor functions
Overall motor function evaluated with the EMFG
Measured: day 21
motor functions
Overall motor function evaluated with the EMFG
Measured: day 51
muscular strength
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Measured: day 1
muscular strength
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Measured: day 21
muscular strength
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Measured: day 51
Body composition measurements
fat body mass
Measured: day 21
Body composition measurements
fat body mass
Measured: day 51
Body composition measurements
lean body mass
Measured: day 21
Body composition measurements
lean body mass
Measured: day 51
brain activated areas
Functional brain connectivity analyzes by functional brain MRI
Measured: day 21
brain activated areas
Functional brain connectivity analyzes by functional brain MRI
Measured: day 51
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jan 2020
- Study start17 Jul 2020
- Primary completion24 Nov 2021
- Study completion24 Nov 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Infantile HemiplegiaStudies of the same condition, open and under way.
- More trials run by University Hospital, Clermont-FerrandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Sponsor type
- University, hospital or other
- Collaborators
- Université d'Auvergne
- Responsible party
- Sponsor
- Investigators
- Catherine Sarret, Principal investigator, University Hospital, Clermont-Ferrand
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04246788
- Sponsor's protocol ID
- RBHP 2019 SARRET
- Other IDs
- 2019-A02218-49
- Acronym
- RIPHIGEO
- Status last verified
- Aug 2026
- First submitted
- 24 Jan 2020
- Last updated
- 6 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Julien L, Moreau-Pernet G, Rochette E, Lemaire JJ, Pontier B, Bourrand S, Pereira B, Chassain C, Sontheimer A, Sarret C. Robot-assisted gait training improves walking and cerebral connectivity in children with unilateral cerebral palsy. Pediatr Res. 2024 Oct;96(5):1306-1315. doi: 10.1038/s41390-024-03240-1. Epub 2024 May 20.
PubMed 38769400
Study at a glance
From the registry record, last updated by the sponsor on 6 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM
- ClinicalTrials.gov ID
- NCT04246788
- Acronym / sponsor ID
- RIPHIGEO / RBHP 2019 SARRET
- Conditions
- Infantile Hemiplegia
- Keywords
- Infantile hemiplegia, Cerebral palsy, Intensive robotic rehabilitation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- University Hospital, Clermont-FerrandUniversity, hospital or other
- Collaborators
- Université d'Auvergne
- Study start
- 17 Jul 2020 (actual)
- Primary completion
- 24 Nov 2021 (actual)
- Study completion
- 24 Nov 2021 (actual)
- First posted
- 29 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cerebral palsy is the most frequent motor deficiency in children. Among other, it can leads to spastic diplegia or hemiplegia. Walking abilities is an important skill to the families' point of view in term of independence in curent life. Improving the walking parameters has been the main objective in several studies of rehabilitation. The G-EO system is a last generation robot assisting gait training that can adjust cadence, walk lengh, ankle and hip angles and other walking parameters to movement captation. Its superiority in terms of walking abilities has been demonstrated in adults with stroke sequelae. Only one study was realized in pediatric patients with spastic diplegia with promising results. The investigators hypothesize that intensive robot-assited gait training using the G-EO system in hemiplegic children can improve their walking abilities.
Detailed description
Objective :
Primary objective: To evaluate walking velocity with the GRAIL (gait real-time analysis and interactive lab) after intensive robot-assisted gait training using the G-EO system in hemiplegic children.
Secondary objectives :Other parameters that will be evaluate include:
- Endurance on the 6 minute walking test
- Joint angles and muscular contraction on the GRAIL
- Number of steps and travelled distance /24h, cardiac frequency and quality of sleep using actimeter bracelet
- Motor functions using the GMFM (Gross Motor Function Measure)
- Spasticity using the modified Ashworth scale
- The functional independence using the Functional Independence Measure (FIM™) for children,
- The quality of life using the Patient Global Impression (PGI-I)
- Muscular strength using the muscular testing cotation scale
- The musculo-squeletal and adipose composition using the peripherical quantitative computed tomography (pQCT)
- The cerebral area activation using functional MRI Study Type: Controlled randomized pilote study Number of centres: Monocentric study, University hospital of Clermont-Ferrand
Study procedure:
- Experimental group: 5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
- Control group : 3 sessions per week of 30 minutes of classical physiotherapy during two weeks
Study evaluation:
T0 : before rehabilitation :
- Actimeter for 24h
- 6 min walking test
- GRAIL
- Modified Ashworth scale
- FIM for children
- GMFM
- Muscular testing scale
- pQCT
- fMRI
T1 : one month after rehabilitation :
- idem T0
- PGI-I questionnary Principal judgement criteria: Walking velocity Secondary judgement criteria: endurance, joint angles, number of steps and travelled distance per 24h, quality of sleep, cardiac frequency, spasticity, functional independence, motor functions, muscular strength, musculo-squeletal and adipose composition, brain activated areas.
Number of subjects:
- 20 patients in the experimental group
- 20 patients in the control group All patients enrolled in the control group will benefit of the GEOsystem rehabilitation at the end of the protocole
Inclusion criteria:
Hemiplegic children aged from 4 to 18 years, with a GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement. Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
Non inclusion criteria:
No lower limb involvement, spasticity = 4 on the modified Ashworth scale, severe cardiorespiratory disease forbidding the rehabilitation program, orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.
Study calendar:
- Starting inclusions: March 2020
- Experimental procedure: March 2020 to March 2021
- Data analyses and synthesis: April 2021 to Dember 2021
Statistical analyses Statistical analysis will be performed using Stata 13 software (Stata-Corp, College Station, TX) by an experimented statistician (Bruno Pereira) working in the university hospital of Clermont-Ferrand. A type-I error set at α=0.05 will be considered. Monovariate and multivariate analyses considering age as a covariable will be performed.
Ethical considerations This study has already been presented at the local ethical committee and will be presented in July 2019 at the national " comité de protection des personnes ". Written informed consent from both parents will be collected at the inclusion. This study will be in agreement with the declaration of Helsinki and the current regulations of clinical trials. It will be declared on the internet site "clinicaltrials.gov".
Expected results :
Intensive robot-assisted gait training using the G-EO system may improve the walking abilities in children with infantile hemiplegia and consequently improve their independence and quality of life. Musculo-squeletal parameters and profile of cerebral activated areas involved in praxia may also be modified by this intensive rehabilitation.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Cohort 1 : experimental group | Experimental | Other: Intensive robotic rehabilitation5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks |
| Cohort 2 : controle group | Active comparator | Other: classical physiotherapy3 sessions per week of 30 minutes of classical physiotherapy during two weeks |
Who may qualify
- Ages
- 4 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (5 listed)
- Hemiplegic children aged from 4 to 18 years
- GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement.
- Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
- Free and informed consent of holders of parental authority and of the patient
- Affiliated to the social security system
Key exclusion criteria (4 listed)
- No lower limb involvement,
- spasticity = 4 on the modified Ashworth scale,
- severe cardiorespiratory disease forbidding the rehabilitation program,
- orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intensive robotic rehabilitation5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks | Other | Cohort 1 : experimental group |
| classical physiotherapy3 sessions per week of 30 minutes of classical physiotherapy during two weeks | Other | Cohort 2 : controle group |
Primary outcome
Gait speed
Time frame: day 1
gait speed assessed during a gait assessment session using the GRAIL system
Gait speed
Time frame: day 21
gait speed assessed during a gait assessment session using the GRAIL system
Gait speed
Time frame: day 51
gait speed assessed during a gait assessment session using the GRAIL system
36 secondary outcomes
6 min. walk test (6-WT)
Time frame: day 1
6 min. walk test (6-WT)
Time frame: day 21
6 min. walk test (6-WT)
Time frame: day 51
joint angles
Time frame: day 1
joint angles
Time frame: day 21
joint angles
Time frame: day 51
number of steps per 24h
Time frame: day 1
number of steps per 24h
Time frame: day 21
number of steps per 24h
Time frame: day 51
travelled distance
Time frame: day 1
travelled distance
Time frame: day 21
travelled distance
Time frame: day 51
quality of sleep: wristband actimeter
Time frame: day 1
quality of sleep: wristband actimeter
Time frame: day 21
quality of sleep: wristband actimeter
Time frame: day 51
cardiac frequency
Time frame: day 1
cardiac frequency
Time frame: day 21
cardiac frequency
Time frame: day 51
Evaluation of spasticity
Time frame: day 1
Evaluation of spasticity
Time frame: day 21
Evaluation of spasticity
Time frame: day 51
functional independence
Time frame: day 1
functional independence
Time frame: day 21
functional independence
Time frame: day 51
motor functions
Time frame: day 1
motor functions
Time frame: day 21
motor functions
Time frame: day 51
muscular strength
Time frame: day 1
muscular strength
Time frame: day 21
muscular strength
Time frame: day 51
Body composition measurements
Time frame: day 21
Body composition measurements
Time frame: day 51
Body composition measurements
Time frame: day 21
Body composition measurements
Time frame: day 51
brain activated areas
Time frame: day 21
brain activated areas
Time frame: day 51
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Aug 2026.
- Results publication: PubMed 38769400Julien L, Moreau-Pernet G, Rochette E, Lemaire JJ, Pontier B, Bourrand S, Pereira B, Chassain C, Sontheimer A, Sarret C. Robot-assisted gait training improves walking and cerebral connectivity in children with unilateral cerebral palsy. Pediatr Res. 2024 Oct;96(5):1306-1315. doi: 10.1038/s41390-024-03240-1. Epub 2024 May 20.
Related trials for Infantile Hemiplegia
Not yet recruiting
Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy
Cerebral Palsy, Hemiplegia, Infantile
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Catherine Sarret principal investigator
University Hospital, Clermont-Ferrand
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intensive robotic rehabilitation and classical physiotherapy in people with Infantile Hemiplegia, run by University Hospital, Clermont-Ferrand at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gait speed (time frame: day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04246788, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.